Ireland trumpets Pfizer biotech facility

Pfizer is keeping mum about a biologics facility it's preparing to build in Ireland, but no one else appears to be. Jacobs Engineering, which Pfizer tapped to perform pre-construction services at the site, trumpeted its selection in a press release. And the Irish newspapers, encouraged by the prospect of 100 new high-tech jobs, are all over the story.

"Cork County Council recently granted planning permission for the facility,": writes the Irish Examiner, "and if the plan is approved by Pfizer construction should begin immediately, with the facility expected to be completed by early 2009."

The drug maker says that the proposed biologics facility still hasn't received final, internal approval, and that hiring Jacobs was only a necessary step in its decision-making process. A final determination is expected in October.

- check out the press release from Jacobs
- read this article from the Irish Examiner

Related Articles:
Troubled Pfizer blueprints biotech venture effort. Report
Pfizer to invest $50M in biotech start-ups. Report

Suggested Articles

Post-Tesaro buyout, don’t expect GlaxoSmithKline to spring for more commercial-stage oncology products anytime soon.

Already a fast-growing blockbuster, Novo Nordisk's injectable Ozempic won a major heart-helping FDA nod that could bode well for its oral sibling.

Bayer's new Vitrakvi for tumors with NTRK gene fusions is meeting skepticism in England and Germany, where cost watchdogs on Friday rejected it.